APP and Alzheimer disease: Numerous AD-linked mutations in amyloid precursor protein (APP) and presenilins (PS) [1-3] alter APP metabolism resulting in accumulation of Aβ42, a 42-amino acid product essential for the formation of parenchymal and vascular amyloid deposits [4], and proposed to initiate the cascade leading to AD [3].